On Monday, Bunge Ltd (NYSE:BG)’s shares declined -3.79% to $86.12.
Bunge Limited (BG) declared that Paul Cornet de Ways-Ruart has been designated to its Board of Directors, effective right away.
Mr. Cornet, age 47, held senior roles at Yahoo! EMEA from 2006-2011, where he led Corporate Development before becoming its Senior Finance Director and Chief of Staff. Formerly, Mr. Cornet was Director of Strategy at Orange UK, a mobile network operator and internet service provider, and worked with McKinsey & Company in London and Palo Alto, California. He holds a Master’s Degree in Engineering and Administration from the Catholic University of Louvain and an MBA from the University of Chicago. A Belgian citizen, Mr. Cornet is a descendant of one of Bunge’s founding families.
Bunge Limited, through its auxiliaries, operates as an agribusiness and food company worldwide. It operates in five segments: Agribusiness, Edible Oil Products, Milling Products, Sugar and Bioenergy, and Fertilizer. The Agribusiness segment engages in the purchase, storage, transport, processing, and sale of agricultural commodities and commodity products, such as oilseeds and grains, counting soybeans, rapeseed, canola, sunflower seeds, wheat, and corn to animal feed manufacturers, livestock producers, wheat and corn millers, other oilseed processors, third-party edible oil processing companies, and biodiesel industries.
Allergan PLC (NYSE:AGN)’s shares dropped -0.03% to $306.62.
American Capital Agency Corp. (AGNC) declared that its Board of Directors has declared a cash dividend on its 8.000% Series A Cumulative Redeemable Preferred Stock (the “Series A Preferred Stock”) (AGNCP) of $0.50 per share for the second quarter 2015. The dividend is payable on July 15, 2015 to preferred shareholders of record as of July 1, 2015, with an ex-dividend date of June 29, 2015.
In addition, AGNC’s Board of Directors has declared a cash dividend on its 7.750% Series B Cumulative Redeemable Preferred Stock (the “Series B Preferred Stock”) underlying its outstanding depositary shares (AGNCB), equivalent to $0.484375 per depositary share for the second quarter 2015. Each depositary share represents a 1/1,000th interest in a share of the Series B Preferred Stock. The dividend is payable on July 15, 2015 to preferred shareholders of record as of July 1, 2015, with an ex-dividend date of June 29, 2015.
American Capital Agency Corp. operates as a real estate investment trust (REIT) in the United States. The company invests in residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by government-sponsored enterprise or by the United States government agency. It funds its investments primarily through short-term borrowings structured as repurchase agreements.
At the end of Monday’s trade, Mallinckrodt PLC (NYSE:MNK)‘s shares surged 0.22% to $119.63.
MannKind Corporation (MNKD), a leading biopharmaceutical company focused on patient experience, acknowledged today that Executive Chairman Alfred Mann was honored last night at a gala for his extensive work in the progression and advancement of diabetes technologies and advocacy.
Held in conjunction with the 75th annual American Diabetes Association Scientific Sessions in Boston, the reception was co-hosted by Kelly L. Close, leading diabetes advocate and founder of the diaTribe Foundation, along with Dr. Steven Edelman, nationally recognized endocrinologist and founder of Take Control of Your Diabetes (TCOYD). In addition to last night’s honors, Mr. Mann was also recently awarded the JDRF’s Lifetime Achievement Award, one of the leading awards in diabetes internationally.
MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes in the United States. Its lead product is AFREZZA inhalation powder, an insulin to control high blood sugar in adult patients with type 1 and type 2 diabetes. MannKind Corporation was founded in 1991 and is headquartered in Valencia, California.
Manulife Financial Corporation (USA) (NYSE:MFC), ended its Monday’s trading session with -1.64% loss, and closed at $18.24.
Manulife Financial Corporation declared that its U.S. Division (John Hancock Financial) has successfully accomplished its formerly declared reinsurance transaction through which New York Life has assumed, on a reinsurance basis, a net 60 percent interest in John Hancock’s in-force participating life insurance closed block, which was written prior to John Hancock’s demutualization in 2000. John Hancock will continue to service the policies and there will be no change in contract terms or policyholder benefits as a result of the reinsurance.
The reinsurance transaction was declared on December 23, 2014, together with a contract under which John Hancock would acquire New York Life’s Retirement Plan Services (RPS) business. The acquisition of the Retirement Plans Services business closed on April 14, 2015.
Manulife Financial Corporation, together with its auxiliaries, provides financial protection and wealth administration products and services to individual, corporate, and business customers primarily in Asia, Canada, and the United States. It offers various individual life and health insurance, and individual and group long-term care insurance products through insurance agents, brokers, banks, financial planners, and direct marketing.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
